Clinical trial
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in…
NCT00320775 · Regeneron Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00320775 |
|---|---|
| Title | Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD |
| Official title | An Exploratory Study of the Safety, Tolerability and Biological Effect of Intravitreal Administration of VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration |
| Lead sponsor | Regeneron Pharmaceuticals, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | VEGF Trap |
| Enrollment | 51 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | May 3, 2006 |
| Last update posted | Mar 18, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: